Rationale
Nearly one in four U.S. households have someone who suffers from migraine headaches, totaling more than 30 million people.
Intracellular calcium dysregulation has been cited as an important mechanism as a source of migraine headaches. Experts have identified abnormally functioning calcium channels, which transport electrical calcium into the brain cell, as a reason for excessively high levels of calcium and subsequent overstimulation as a key contributor to migraine headaches.
Trial Description
Purpose
The purpose of the Online Migraine Trial is to determine if apoaequorin may improve quality of life measures in adults with recurring migraine headaches. Apoaequorin works by buffering excessive calcium in brain nerve cells and may reduce pain and frequency of headaches.
Primary Outcome Measures
- Improvements in quality of life (i.e., physical, emotional and social) for participants who are migraine sufferers
- Improvements in the impact of migraine pain on daily activities
- Improvements in the effect of migraines on participants' emotion and functional well-being
Apply for the Online Migraine Trial today!
Individuals interested in applying to the Online Migraine Trial can apply here. A representative will contact you to continue the enrollment process.